WHO Antenatal Care Guideline Implementation Guide
0.3.0 - CI Build International flag

WHO Antenatal Care Guideline Implementation Guide, published by World Health Organization (WHO). This guide is not an authorized publication; it is the continuous build for version 0.3.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/WorldHealthOrganization/smart-anc/ and changes regularly. See the Directory of published versions

: ANC.DT.10 Hepatitis C testing - XML Representation

Active as of 2021-06-11

Raw xml | Download



<PlanDefinition xmlns="http://hl7.org/fhir">
  <id value="ANCDT10"/>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml">
    <table class="grid dict">
        
        <tr>
            <th scope="row"><b>Id: </b></th>
            <td style="padding-left: 4px;">ANCDT10</td>
        </tr>
        
        
        <tr>
            <th scope="row"><b>Url: </b></th>
            <td style="padding-left: 4px;"><a href="PlanDefinition-ANCDT10.html">ANC.DT.10 Hepatitis C testing</a></td>
        </tr>
        
        
        <tr>
            <th scope="row"><b>Version: </b></th>
            <td style="padding-left: 4px;">0.3.0</td>
        </tr>
        
        
        <tr>
            <th scope="row"><b>Identifier: </b></th>
            <td style="padding-left: 4px;">
                
                
                <p style="margin-bottom: 5px;">
                    <b>value: </b> <span>ANC.DT.10</span>
                </p>
                
            </td>
        </tr>
        
        
        <tr>
            <th scope="row"><b>Name: </b></th>
            <td style="padding-left: 4px;">ANCDT10</td>
        </tr>
        
        
        <tr>
            <th scope="row"><b>Title: </b></th>
            <td style="padding-left: 4px;">ANC.DT.10 Hepatitis C testing</td>
        </tr>
        
        
        
        <tr>
            <th scope="row"><b>Status: </b></th>
            <td style="padding-left: 4px;">active</td>
        </tr>
        
        
        <tr>
            <th scope="row"><b>Experimental: </b></th>
            <td style="padding-left: 4px;">false</td>
        </tr>
        
        
        <tr>
            <th scope="row"><b>Type: </b></th>
            <td style="padding-left: 4px;">
                
                    
                        
                        <p style="margin-bottom: 5px;">
                            <b>system: </b> <span><a href="http://hl7.org/fhir/R4/codesystem-plan-definition-type.html">http://terminology.hl7.org/CodeSystem/plan-definition-type</a></span>
                        </p>
                        
                        
                        <p style="margin-bottom: 5px;">
                            <b>code: </b> <span>eca-rule</span>
                        </p>
                        
                        
                    
                
                
            </td>
        </tr>
        
        
        
        <tr>
            <th scope="row"><b>Date: </b></th>
            <td style="padding-left: 4px;">2021-06-11 23:02:59-0600</td>
        </tr>
        
        
        <tr>
            <th scope="row"><b>Publisher: </b></th>
            <td style="padding-left: 4px;">World Health Organization (WHO)</td>
        </tr>
        
        
        <tr>
            <th scope="row"><b>Description: </b></th>
            <td style="padding-left: 4px;">Depending on the population prevalence, and woman's medical history, conduct hepatitis C testing</td>
        </tr>
        
        
        
        
        <tr>
            <th scope="row"><b>Use Context: </b></th>
            <td style="padding-left: 4px;">
                <table class="grid-dict">
                    <tr><th><b>code</b></th><th><b>value</b></th><th><b>display</b></th></tr>
                    
                      <tr>
                        <td>task</td>
                        <td>ANC.B9.</td>
                        <td>Conduct laboratory tests and imaging</td>
                      </tr>
                    
                </table>
            </td>
        </tr>
        
        
        <tr>
            <th scope="row"><b>Jurisdiction: </b></th>
            <td style="padding-left: 4px;">001</td>
        </tr>
        
        
        
        
        
        
        
        

        
        <tr>
          <th scope="row"><b>Libraries: </b></th>
          <td style="padding-left: 4px;">
            <table class="grid-dict">
              
                <tr><td><a href="Library-ANCDT10.html">ANC.DT.10 Hepatitis C testing</a></td></tr>
              
            </table>
          </td>
        </tr>
        

        
        <tr>
          <th scope="row"><b>Actions: </b></th>
          <td style="padding-left: 4px;">
            <table class="grid-dict">
              
                <tr>
                  <td>
                    <b> ANC.DT.10 Hepatitis C testing:</b> <br/>
                    <b>When:</b> <i>Named Event:</i> ANC.B9. Conduct laboratory tests and imaging<br/>
                    
                    
                      <b>Then:</b>
                      <table class="grid-dict">
                        
                          <tr>
                            <td>
                              In settings where the proportion of HCV antibody seroprevalence in the general population is 2% or higher, then a hepatitis C test is required.

Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing.<br/>
                              
                              <b>If:</b> <i>Applicability:</i> &amp;quot;Population prevalence of hepatitis C&amp;quot; ≥ 2% <i>(Should Conduct hepatitis C test)</i><br/>
                              
                                
                              
                            </td>
                          </tr>
                        
                          <tr>
                            <td>
                              If the woman is HIV positive, then a hepatitis C test is required.

Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing<br/>
                              
                              <b>If:</b> <i>Applicability:</i> &amp;quot;HIV status&amp;quot; = &amp;quot;HIV positive&amp;quot; <i>(Should Conduct hepatitis C test 2)</i><br/>
                              
                                
                              
                            </td>
                          </tr>
                        
                          <tr>
                            <td>
                              If the woman injects drugs, then a hepatitis C test is required.

Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing.<br/>
                              
                              <b>If:</b> <i>Applicability:</i> &amp;quot;Current alcohol and/or other substance use&amp;quot; = &amp;quot;Injectable drugs&amp;quot; <i>(Should Conduct hepatitis C test 3)</i><br/>
                              
                                
                              
                            </td>
                          </tr>
                        
                          <tr>
                            <td>
                              If a woman is a sex worker, then a hepatitis C test is required.

Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing.<br/>
                              
                              <b>If:</b> <i>Applicability:</i> &amp;quot;Occupation&amp;quot; = &amp;quot;Informal employment (sex worker)&amp;quot; <i>(Should Conduct hepatitis C test 4)</i><br/>
                              
                                
                              
                            </td>
                          </tr>
                        
                      </table>
                    
                  </td>
                </tr>
              
            </table>
          </td>
        </tr>
        
    </table>
</div>
  </text>
  <url value="http://fhir.org/guides/who/anc-cds/PlanDefinition/ANCDT10"/>
  <identifier>
    <use value="official"/>
    <value value="ANC.DT.10"/>
  </identifier>
  <version value="0.3.0"/>
  <name value="ANCDT10"/>
  <title value="ANC.DT.10 Hepatitis C testing"/>
  <type>
    <coding>
      <system
              value="http://terminology.hl7.org/CodeSystem/plan-definition-type"/>
      <code value="eca-rule"/>
    </coding>
  </type>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2021-06-11T23:02:59-06:00"/>
  <publisher value="World Health Organization (WHO)"/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="https://www.who.int"/>
    </telecom>
  </contact>
  <description
               value="Depending on the population prevalence, and woman's medical history, conduct hepatitis C testing"/>
  <useContext>
    <code>
      <system
              value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
      <code value="task"/>
      <display value="Workflow Task"/>
    </code>
    <valueCodeableConcept>
      <coding>
        <system
                value="http://fhir.org/guides/who/anc-cds/CodeSystem/activity-codes"/>
        <code value="ANC.B9."/>
        <display value="Conduct laboratory tests and imaging"/>
      </coding>
    </valueCodeableConcept>
  </useContext>
  <jurisdiction>
    <coding>
      <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
      <code value="001"/>
    </coding>
  </jurisdiction>
  <library value="http://fhir.org/guides/who/anc-cds/Library/ANCDT10"/>
  <action>
    <title value="ANC.DT.10 Hepatitis C testing"/>
    <trigger>
      <type value="named-event"/>
      <name value="ANC.B9. Conduct laboratory tests and imaging"/>
    </trigger>
    <action id="1">
      <title value="Conduct hepatitis C test"/>
      <description value="Conduct hepatitis C test"/>
      <textEquivalent
                      value="In settings where the proportion of HCV antibody seroprevalence in the general population is 2% or higher, then a hepatitis C test is required.

Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing."/>
      <documentation>
        <type value="citation"/>
        <label
               value="Guidelines on hepatitis B and C testing (2017): Recommendation 6.1 (4)"/>
      </documentation>
      <condition>
        <kind value="applicability"/>
        <expression>
          <description
                       value="&quot;Population prevalence of hepatitis C&quot; ≥ 2%"/>
          <language value="text/cql-identifier"/>
          <expression value="Should Conduct hepatitis C test"/>
        </expression>
      </condition>
    </action>
    <action id="2">
      <title value="Conduct hepatitis C test"/>
      <description value="Conduct hepatitis C test 2"/>
      <textEquivalent
                      value="If the woman is HIV positive, then a hepatitis C test is required.

Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing"/>
      <documentation>
        <type value="citation"/>
        <label
               value="Guidelines on hepatitis B and C testing (2017): Recommendation 6.1 (4)"/>
      </documentation>
      <condition>
        <kind value="applicability"/>
        <expression>
          <description
                       value="&quot;HIV status&quot; = &quot;HIV positive&quot;"/>
          <language value="text/cql-identifier"/>
          <expression value="Should Conduct hepatitis C test 2"/>
        </expression>
      </condition>
    </action>
    <action id="3">
      <title value="Conduct hepatitis C test"/>
      <description value="Conduct hepatitis C test 3"/>
      <textEquivalent
                      value="If the woman injects drugs, then a hepatitis C test is required.

Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing."/>
      <documentation>
        <type value="citation"/>
        <label
               value="Guidelines on hepatitis B and C testing (2017): Recommendation 6.1 (4)"/>
      </documentation>
      <condition>
        <kind value="applicability"/>
        <expression>
          <description
                       value="&quot;Current alcohol and/or other substance use&quot; = &quot;Injectable drugs&quot;"/>
          <language value="text/cql-identifier"/>
          <expression value="Should Conduct hepatitis C test 3"/>
        </expression>
      </condition>
    </action>
    <action id="4">
      <title value="Conduct hepatitis C test"/>
      <description value="Conduct hepatitis C test 4"/>
      <textEquivalent
                      value="If a woman is a sex worker, then a hepatitis C test is required.

Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing."/>
      <documentation>
        <type value="citation"/>
        <label
               value="Guidelines on hepatitis B and C testing (2017): Recommendation 6.1 (4)"/>
      </documentation>
      <condition>
        <kind value="applicability"/>
        <expression>
          <description
                       value="&quot;Occupation&quot; = &quot;Informal employment (sex worker)&quot;"/>
          <language value="text/cql-identifier"/>
          <expression value="Should Conduct hepatitis C test 4"/>
        </expression>
      </condition>
    </action>
  </action>
</PlanDefinition>